BridgeBio has significantly advanced this development of a innovative therapy for ATTR-CM, leveraging Attruby. Preliminary trial data indicates promising improvements for those affected with this severe condition. The https://bridgebio902184.ssnblog.com/40694685/firm-improves-attr-cm-management-through-the-drug